GeneQuantum and WuXi XDC to empower innovative bioconjugates development

China-based GeneQuantum Healthcare (GQ) and WuXi XDC, a leading global Contract Research, Development and Manufacturing ...

December 28, 2022 | Wednesday | News
Flexibility, Time to market and Strategic collaboration- Key trends of pharma manufacturing in 2023

  In one word, how would you describe 2022? I would describe it as volatile, which means it was very difficult to...

December 19, 2022 | Monday | Opinion
Innoforce opens manufacturing plant in China for CDMO services

Innoforce, a global provider of end-to-end contract development and manufacturing services (CDMO), has announced that it...

December 2, 2022 | Friday | News
Thermo Fisher opens new facility in Hangzhou, China

Thermo Fisher Scientific is opening a new facility in Hangzhou, China, as part of its global effort to help compani...

December 9, 2022 | Friday | News
Catalent completes expansion of clinical supply facility in Shanghai, China

Catalent, the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, lau...

December 9, 2022 | Friday | News
Taiwan's Medeologix buys three Silicon Valley medical device CDMO companies

Medeologix, a Taiwan-based medtech CDMO company, has announced its successful acquisition of three premier medical devic...

November 29, 2022 | Tuesday | News
WuXi opens integrated biologics CRDMO centre in Shanghai

WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organisation (CRDMO), has launched its...

November 22, 2022 | Tuesday | News
WuXi establishes new vaccines CDMO facility in China

WuXi Vaccines, a leading global Contract Development and Manufacturing Organisation (CDMO), has entered into an agreemen...

November 15, 2022 | Tuesday | News
I Peace partners with the California Institute for Regenerative Medicine

Founded in 2015 by Koji Tanabe, a graduate of Professor Shinya Yamanaka's laboratory at Kyoto Univer...

November 3, 2022 | Thursday | News
Terumo invests ¥15 B to expand CDMO services outside Japan

Terumo Pharmaceutical Solutions (TPS), a leading manufacturer of injection, primary container, and infusion therapy devi...

November 1, 2022 | Tuesday | News
Lotte Biologics signs MoU with Huons Global for biologics manufacturing

South Korea-based startup Lotte Biologics has signed a memorandum of understanding (MoU) with Huons Global for clinical ...

November 1, 2022 | Tuesday | News
WuXi Biologics launches new manufacturing facility in China

WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), has successfully...

October 26, 2022 | Wednesday | News
Samsung Biologics unlocks additional capacity for production at newest Plant 4

Samsung Biologics, South Korea-based contract development and manufacturing organization (CDMO), has announced that its ...

October 12, 2022 | Wednesday | News
Fujifilm to establish first Bio-CDMO site in Japan

Fujifilm Corporation has announced that it will establish the company’s first Japanese Bio-CDMO (contract developm...

October 10, 2022 | Monday | News
Cytiva strengthens cell line development with CEVEC acquisition

Global life sciences leader Cytiva has acquired CEVEC Pharmaceuticals, a leading German provider of high-performance cel...

October 6, 2022 | Thursday | News
Samsung Biologics to launch new platforms for antibody development process

South Korea-based Samsung Biologics, a world-leading contract development and manufacturing organization (CDMO), is laun...

September 30, 2022 | Friday | News
Biosyngen boosts cell therapy GMP capabilities in Singapore

Singapore-based startup Biosyngen has signed to set up a cell therapy GMP facility which will serve as a base to develop...

September 28, 2022 | Wednesday | News
WuXi STA opens first high potency oral drug product manufacturing facility

WuXi STA, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has announced the ope...

September 28, 2022 | Wednesday | News